Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population

NCT07652567 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

690

Enrollment

OTHER

Sponsor class

Conditions

High-normal Blood Pressure

Interventions

DRUG: Telmisartan
DRUG: Indapamide
OTHER: Placebo

Sponsor

Qilu Hospital of Shandong University